Department of Radiation Oncology, Michigan Medicine, Ann Arbor, Michigan, USA.
Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
J Appl Clin Med Phys. 2024 Jun;25(6):e14359. doi: 10.1002/acm2.14359. Epub 2024 Apr 30.
AAPM Task Group No. 263U1 (Update to Report No. 263 - Standardizing Nomenclatures in Radiation Oncology) disseminated a survey to receive feedback on utilization, gaps, and means to facilitate further adoption.
The survey was created by TG-263U1 members to solicit feedback from physicists, dosimetrists, and physicians working in radiation oncology. Questions on the adoption of the TG-263 standard were coupled with demographic information, such as clinical role, place of primary employment (e.g., private hospital, academic center), and size of institution. The survey was emailed to all AAPM, AAMD, and ASTRO members.
The survey received 463 responses with 310 completed survey responses used for analysis, of whom most had the clinical role of medical physicist (73%) and the majority were from the United States (83%). There were 83% of respondents who indicated that they believe that having a nomenclature standard is important or very important and 61% had adopted all or portions of TG-263 in their clinics. For those yet to adopt TG-263, the staffing and implementation efforts were the main cause for delaying adoption. Fewer respondents had trouble adopting TG-263 for organs at risk (29%) versus target (44%) nomenclature. Common themes in written feedback were lack of physician support and available resources, especially in vendor systems, to facilitate adoption.
While there is strong support and belief in the benefit of standardized nomenclature, the widespread adoption of TG-263 has been hindered by the effort needed by staff for implementation. Feedback from the survey is being utilized to drive the focus of the update efforts and create tools to facilitate easier adoption of TG-263.
AAPM 工作组 263U1（更新报告 263-放射肿瘤学标准化命名法）发布了一项调查，以征求反馈意见，了解使用情况、差距以及促进进一步采用的方法。
该调查由 TG-263U1 成员创建，以征求从事放射肿瘤学的物理学家、剂量师和医生的反馈意见。关于 TG-263 标准采用的问题与人口统计学信息（如临床角色、主要工作场所（如私人医院、学术中心）和机构规模）相结合。该调查通过电子邮件发送给所有 AAPM、AAMD 和 ASTRO 成员。
该调查收到了 463 份回复，其中 310 份完整的回复用于分析，其中大多数人的临床角色是医学物理学家（73%），大多数来自美国（83%）。有 83%的受访者表示，他们认为拥有命名法标准很重要或非常重要，61%的人已经在他们的诊所中采用了 TG-263 的全部或部分内容。对于那些尚未采用 TG-263 的人来说，人员配备和实施工作是延迟采用的主要原因。对于风险器官（29%）与靶器官（44%）命名法，采用 TG-263 遇到困难的受访者较少。书面反馈中的共同主题是缺乏医生的支持和可用资源，特别是在供应商系统中，以促进采用。
尽管人们强烈支持和相信标准化命名法的好处，但由于实施所需的员工努力，TG-263 的广泛采用受到了阻碍。调查反馈正在被用来推动更新工作的重点，并创建工具，以促进更容易地采用 TG-263。
